wada 2025 prohibited list bpc-157 s0 Reminder: WADA's comes into force on 1 January WADA publishes 2025 Prohibited List

The significance of the gut barrier in disease

Wegovy is suitable for: Adults with a BMI of 30 or higher (obesity) Adults with a BMI of 27 29.9 (overweight) who also have a weight-related condition like type 2 diabetes, high blood pressure, or high cholesterol Individuals whove struggled to lose weight through diet and exercise alone Note: In some ethnic groups, like African, Indian, or Middle Eastern populations, weight-related health risks may occur at a lower BMI

Results appear gradually over 3 to 6 months, including improvements in sleep, energy, muscle mass, and recovery, though individual results vary

It is administered subcutaneously (under the skin) in small doses